Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7897792 Coumarin derivative having antitumor activity

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 9, 2007
Date of Patent
March 1, 2011
Patent Application Number
12161256
Patent Citations Received
‌
US Patent 11702646 Methods for modulating RNA splicing
0
‌
US Patent 11753407 Compounds for treating spinal muscular atrophy
‌
US Patent 12103926 Compounds for treating huntington's disease
0
‌
US Patent 11780839 Compounds for treating Huntington's disease
‌
US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease
0
‌
US Patent 11873296 Solid forms of a dual RAF/MEK inhibitor
0
‌
US Patent 12020432 Tissue phasic classification mapping system and method
0
‌
US Patent 11685746 Heteroaryl compounds for treating Huntington's disease
0
Patent Inventor Names
Kenji Takanashi
0
Fumio Watanabe
0
Hitoshi Iikura
0
Ikumi Hyoudoh
0
Masahiro Sakaitani
0
Masayuki Matsushita
0
Naoki Harada
0
Noriyuki Furuichi
0
Pil-Su Ho
0
Sawako Ozawa
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7897792
Patent Primary Examiner
‌
Nizal S Chandrakumar

Find more entities like US Patent 7897792 Coumarin derivative having antitumor activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.